STAT3: Too much may be worse than not enough!

Blood

Volumn 125, Issue 4, 2015, Pages 583-584

  Haddad, Elie ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

STAT1 PROTEIN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN;

ASYMPTOMATIC DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CYTOPENIA; DISEASE ASSOCIATION; ENTEROPATHY; GAIN OF FUNCTION MUTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; LOSS OF FUNCTION MUTATION; LYMPHADENOPATHY; LYMPHOCYTE PROLIFERATION; MEMORY CELL; NATURAL KILLER CELL; NOTE; PENETRANCE; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECURRENT INFECTION; SHORT STATURE; SKIN MANIFESTATION; TH17 CELL; AUTOIMMUNE DISEASE; FEMALE; GENETIC DISORDER; GENETICS; LYMPHOPROLIFERATIVE DISEASE; MALE;

AUTOIMMUNE DISEASES; FEMALE; GENETIC DISEASES, INBORN; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; MALE; STAT3 TRANSCRIPTION FACTOR;

EID: 84921493915     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-11-610592     Document Type: Note

References (13)

1. Milner JD, Vogel TP, Forbes L, et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood. 2015;125(4):591-599.
2. Haapaniemi EM, Kaustio M, Rajala HLM, et al. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood. 2015;125(4):639-648.
3. Flanagan SE, Haapaniemi E, RussellMA, et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat Genet. 2014;46(8):812-814.
4. Uzel G, Sampaio EP, Lawrence MG, et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol. 2013;131(6):1611-1623.
5. Qi QR, Yang ZM. Regulation and function of signal transducer and activator of transcription 3. World J Biol Chem. 2014;5(2):231-239.
6. de Beaucoudrey L, Puel A, Filipe-Santos O, et al. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med. 2008;205(7):1543-1550.
7. Ma CS, Avery DT, Chan A, et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood. 2012;119(17):3997-4008.
8. Deenick EK, Avery DT, Chan A, et al. Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells. J Exp Med. 2013;210(12):2739-2753.
9. Carow B, Rottenberg ME. SOCS3, a major regulator of infection and inflammation. Front Immunol. 2014;5:58.
10. Averbuch D, Chapgier A, Boisson-Dupuis S, Casanova JL, Engelhard D. The clinical spectrum of patients with deficiency of signal transducer and activator of transcription-1. Pediatr Infect Dis J. 2011;30(4):352-355.
11. Zhang HF, Lai R. STAT3 in cancer-friend or foe? Cancers (Basel). 2014;6(3):1408-1440.
12. Le DT, Shannon KM. Ras processing as a therapeutic target in hematologic malignancies. Curr Opin Hematol. 2002;9(4):308-315.
13. Niemela JE, Lu L, Fleisher TA, et al. Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasis. Blood. 2011;117(10):2883-2886.